Commonly used antibiotic shows promise for combating Zika infections
24/11/2020
NIH preclinical study suggests FDA-approved tetracycline-based antibiotics may slow infection and reduce neurological problems.
NIH preclinical study suggests FDA-approved tetracycline-based antibiotics may slow infection and reduce neurological problems.